The Process of Apoptosis in a Holocrine Gland as Shown by the Avian Uropygial Gland

Anatomical Record

Volumn 296, Issue 3, 2013, Pages 504-520

  Liman, Narin ^a   Alan, Emel ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Bax; Chicken; Holocrine; PCNA; Survivin; Uropygial gland

Indexed keywords

CYCLINE; PROTEIN BAX; SURVIVIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS; CHICKEN; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM; FEMALE; HOLOCRINE GLAND; IMMUNOREACTIVITY; NICK END LABELING; NONHUMAN; ORGAN SYSTEMS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UROPHYGIAL GLAND;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; AVIAN PROTEINS; BCL-2-ASSOCIATED X PROTEIN; CELL DIFFERENTIATION; CELL PROLIFERATION; CHICKENS; EXOCRINE GLANDS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INHIBITOR OF APOPTOSIS PROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN;

AVES;

EID: 84873748502     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.22645     Document Type: Article

References (105)

1. Altieri DC. 2006. The case for survivin as a regulator of microtubule dynamics and cell-death decisions. Curr Opin Cell Biol 18:609-615.
2. Altieri DC. 2010. Survivin and IAP proteins in cell-death mechanisms. Biochem J 430:190-205.
3. Ambrosini G, Adida C, Altieri DC. 1997. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921.
4. Bandyopadhyay A, Bhattacharyya SP. 1999. Influence of fowl uropygial gland and its secretory lipids components on the growth of skin surface fungi of fowl. Indian J Exp Biol 37:1218-1222.
5. Batinac T, Zamolo G, Hadžisejdić I, Zauhar G, Brumini G, Ruzić A, Persić V. 2007. Expression of Bcl-2 family proteins in psoriasis. Croat Med J 48:319-326.
6. Blanc-Brude OP, Yu J, Simosa H, Conte MS, Sessa MC, Altieri DC. 2002. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8:987-994.
7. Blanpain C, Fuchs E. 2009. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol 10:207-217.
8. Bongiovanni L, Malatesta D, Della Salda L. 2009a. Survivin expression in canine tumours with sebaceous differentiation. J Comp Pathol 141:281.
9. Bongiovanni L, Colombi I, Fortunato C, Della Salda L. 2009b. Survivin expression in canine epidermis and in canine and human cutaneous squamous cell carcinomas. Vet Dermatol 20:369-376.
10. Bongiovanni L, Muller EJ, Della Salda L. 2011. Survivin in skin pathologies. Exp Dermatol 20:457-463.
11. Bongiovanni L, Suter MM, Malatesta D, Ordinelli A, Ciccarelli A, Romanucci M, Brenner O and Della Salda L. 2012. Nuclear survivin expression as a potentially useful tool for the diagnosis of canine cutaneous sebaceous lesions. Vet Dermatol 23:394-e73.
12. Botchkareva NV, Kahn M, Ahluwalia G, Shander D. 2007. Survivin in the human hair follicle. J Invest Dermatol 127:479-482.
13. Bravo R, Frank R, Blundell PA, MacDonald-Bravo H. 1987. Cyclin/PCNA is the auxiliary protein of DNA polymerase δ. Nature 326:515-517.
14. Capano M, Crompton M. 2002. Biphasic translocation of Bax to mitochondria. Biochem J 367:169-178.
15. Chao DT, Korsmeyer SJ. 1998. BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419.
16. Chan KS, Wong CH, Huang YF, Li HY. 2010. Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis. Cell Death Dis 1:e57.
17. Chiou SK, Jones MK, Tarnawski AS. 2003. Survivin-an anti-apoptosis protein: its biological roles and implications for cancer and beyond. Med Sci Monit 9:143.
18. Chiodino C, Cesinaro AM, Ottani D, Fantini F, Giannetti A, Trentini GP, Pincelli C. 1999. Expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol 113:415-418.
19. Cho S, Hahm J-H, Hong Y-S. 2001. Analysis of p53 and Bax mutations, loss of heterozygosity, p53 and bcl-2 expression and apoptosis in basal cell carcinoma in Korean patients. Br J Dermatol 144:841-848.
20. Colnaghi R, Connell CM, Barrett RM, Wheatley SP. 2006. Separating the anti-apoptotic and mitotic roles of survivin. J Biol Chem 281:33450-33456.
21. Conlon I, Raff M. 1999. Size control in animal development. Cell 96:235-244.
22. Connell CM, Colnaghi R, Wheatley SP. 2008. Nuclear survivin has reduced stability and is not cytoprotective. J Biol Chem 238:3289-3296.
23. Crossmon GA. 1937. Modification of Mallory's connective tissue stain with a discussion of the principles involved. Anat Rec 69:33-38.
24. Dallaglio K, Marconi A, Pincelli C. 2012. Survivin: a dual player in healthy and diseased skin. J Invest Dermatol 132:18-27.
25. De Giorgi F, Lartigue L, Bauer M K, Schubert A, Grimm S, Hanson G T, Remington SJ, Youle RJ, Ichas F. 2002. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 16:607-609.
26. Dohi T, Beltrami E, Wall NR, Plescia J, Altier DC. 2004. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest 114:1117-1127.
27. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC. 2002. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115:575-585.
28. Fukuda S, Pelus LM. 2001. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34 (+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood 98:2091-2100.
29. Gao CF, Ren S, Zhang L, Nakajima T, Ichinose S, Hara T, Koike K, Tsuchida N. 2001. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis. Exp Cell Res 265:145-151.
30. Gavrieli Y, Sherman Y, Ben-Sasson SA. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501.
31. Georgel P, Crozat K, Lauth X, Makrantonaki E, Seltmann H, Sovath S, Hoebe K, Du X, Rutschmann S, Jiang Z, Bigby T, Nizet V, Zouboulis CC, Beutler B. 2005. A TLR2-responsive lipid effector pathway protects mammals against Gram-positive bacterial skin infections. Infect Immun 73:4512-4521.
32. Ghazizadeh S, Taichman LB. 2001. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J 20:1215-1222.
33. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR. 2001. Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa. Hum Pathol 32:119-125.
34. Goodridge AG, Carpenter WR, Fisch JE, Goldman MJ, Kameda K, Stapleton SR. 1989. Structure and regulation of the avian gene for fatty acid synthase. Reprod Nutr Dev 29:359-375.
35. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudrlka H, Bukowska K, Bursch W, Schulte-Hermann R. 1995. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 21: 1465-1468.
36. Haake AR, Polakowska RR. 1995. UV-induced apoptosis in skin equivalents: inhibition by phorbol ester and bcl-2 expression. Cell Death Differ 2:183-193.
37. Henrikson RC, Kaye GI, Mazurkiewicz JE. 1997. NMS Histology. 1st ed. Baltimore: Lippincott Williams and Wilkins.
38. Hipfner DR, Cohen SM. 2004. Connecting proliferation and apoptosis in development and disease. Nat Rev Mol Cell Biol 5:805-815.
39. Horsley V, O'Carroll D, Tooze R, Ohinata Y, Saitou M, Obukhanych T, Nussenzweig M, Tarakhovsky A, Fuchs E. 2006. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell 126:597-609.
40. L during apoptosis. Proc Nat Acad Sci USA 94:3668-3672.
41. Jaattela M. 1999. Escaping cell death: survival proteins in cancer. Exp Cell Res 248:30-43.
42. Jacob J, Ziswiler V. 1982. The uropygial gland. In: Farner DS, King JR, Parkes KC, eds. Avian biology. New York: Academic Press. p 199-324.
43. Jenik RA, Fisch JE, Goodridge AG. 1987. Terminal differentiation in the avian uropygial gland. Accumulation of fatty acid synthase and malic enzyme in non-dividing cells. Cell Tissue Res 250:315-321.
44. Jenkinson DM, Elder HY, Montgomery I, Moss VA. 1985. Comparative studies of the ultrastructure of the sebaceous gland. Tissue Cell 17:683-698.
45. Jeong E, Hong JW, Min JA, Lee DW, Sohn MY, Lee WJ, Lee JY, Park YM. 2011. Topical ALA-photodynamic therapy for acne can induce apoptosis of sebocytes and down-regulate their TLR-2 and TLR-4 expression. Ann Dermatol 23:23-32.
46. Johnson ME, Howerth EW. 2004. Survivin: A bifunctional inhibitor of apoptosis protein. Vet Pathol 41:599-607.
47. Khan S, Aspe JR, Asumen MG, Almaguel F, Odumosu O, Acevedo-Martinez S, DeLeon M, Langridge WHR, Wall NR. 2009. Extracellular, cell permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential. Br J Cancer 100:1073-1086.
48. Khan S, Jutzy JMS, Aspe JR, McGregor DW, Neidigh JW, Wall NR. 2011. Survivin is released from cancer cells via exosomes. Apoptosis 16:1-12.
49. Kishimoto S, Shibagaki R, Nagata M, Takenaka H, Yasuno H. 1999. Detection of apoptosis in hair follicles and acrosyringium of normal human scalp skin by labeling of nick ends of fragmented DNA. Arch Dermatol Res 291:300-302.
50. Knauer SK, Mann W, Stauber RH. 2007. Survivin's dual role: an export's view. Cell Cycle 6:518-521.
51. Kobayashi Y, Yukiue H, Sasaki H, Fukai I, Yokoyama T, Kiriyama M, Yamakawa Y, Maeda M, Fujii Y. 2002. Developmentally regulated expression of survivin in the human thymus. Hum Immunol 63:101-107.
52. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S. 2000. Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 6:529-534.
53. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. 1994. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol 145:1323-1336.
54. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM. 1986. Expression of proliferating cell nuclear antigen (PCNA/cyclin) during the cell cycle. Exp Cell Res 166:209-219.
55. Lehner R, Bobak J, Kim NW, Shroyer AL Shroyer KR. 2001. Localization of telomerase hTERT protein and survivin in placenta: relation to placental development and hydatidiform mole. Obstet Gynaecol 97:965-970.
56. Lens SM, Vader G, Medema RH. 2006. The case for survivin as mitotic regulator. Curr Opin Cell Biol 18:616-622.
57. Li F. 2003. Survivin study: what is the next wave? J Cell Physiol 197:8-29.
58. Li F, Ambrosini G, Chu EY, Plescia J, Toqnin S, Marchisio PC, Altieri DC. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
59. Liman N, Alan E, Beyaz F. 2009. Immunohistochemical demonstration of S-100 protein in the chicken uropygial gland during the post-hatching period. Zool Sci 26:600-607.
60. Liman N, Alan E, Bayram GK, Gurbulak K. 2012. Expression of survivin, Bcl-2 and Bax proteins in the domestic cat (Felis catus) endometrium during the oestrus cycle. Reprod Domest Anim. DOI: 10.1111/j.1439-0531.2012.02021.x.
61. Maga G, Hübscher U. 1995. DNA polymerase epsilon interacts with proliferating cell nuclear antigen in primer recognition and elongation. Biochemistry 34:891-901.
62. Marconi A, Dallaglio K, Lotti R, Vaschieri C, Truzzi F, Fantini F, Pincelli C. 2007. Survivin identifies keratinocyte stem cells and is downregulated by anti-beta1 integrin during anoikis. Stem Cells 25:149-155.
63. WAF1 compartmentalisation in sebaceous carcinoma compared with sebaceous hyperplasia and sebaceous adenoma. J Clin Pathol 55:763-766.
64. McCall CA, Cohen JJ. 1991. Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 97:111-114.
65. Moldovan GL, Pfander B, Jentsch S. 2007. PCNA, the maestro of the replication fork. Cell 129:665-679.
66. Morris GF, Mathews MB. 1989. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 264:13856-13864.
67. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA, Cotsarelis G. 2004. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol 22:411-417.
68. Nelson AM, Zhao W, Gilliland KL, Zaenqlein AL, Liu W, Thiboutot DM. 2008. Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cells. J Clin Invest 118:1468-1478.
69. Nelson AM, Conq Z, Gilliland KL, Thiboutot DM. 2011. TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells. Br J Dermatol 165:526-533.
70. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS, Altieri DC. 2000. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398.
71. Oltvai ZN, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74:609-619.
72. Panteleyev AA, Rosenbach T, Paus R, Christiano AM. 2000. The bulge is the source of cellular renewal in the sebaceous gland of mouse skin. Arch Dermatol Res 292:573-576.
73. Pasquier DD, Phung AC, Ymlahi-Ouazzani Q, Sizella, L, Ballaqny C, Bronchain C, Du Pasquier L, Mazabraud A. 2006. Survivin increased vascular development during Xenopus ontogenesis. Differentiation 74:244-253.
74. Paunesku T, Mittal S, Protić M, Oryhon J, Korolev SV, Joachimiak A, Woloschak GE. 2001. Proliferating cell nuclear antigen (PCNA): ringmaster of thegenome. IntJ Radiat Biol 77:1007-1021.
75. Piérard-Franchimont C, Quatresooz P, Piérard GR. 2010. Sebum production. In: Farage MA, Miller KW, Maibach HI, editors. Textbook of aging skin. Berlin Heidelberg: Springer-Verlag. p 343-352.
76. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, Stillman B. 1987. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326:517-520.
77. Reneerkens J, Versteegh MA, Scneider AM, Piersma T, Burtt EH. 2008. Seasonally changing preen-wax composition: red knots'(Calidris canutus) flexible defense against feather-degrading bacteria? Auk 121:656-659.
78. Riss TL. 2001. Apoptosis as a biomarker in chemoprevention trials. Urology 50:141-142.
79. Rodriguez JA, Span SW, Ferreira CG, Kruyt FA, Giaccone G. 2002. CRM1-mediated nuclear export determines the cytoplasmic localization of the antiapoptotic protein Survivin. Exp Cell Res 275:44-53.
80. Rumble JM, Duckett CS. 2008. Diverse functions within the IAP family. J Cell Sci 121:3505-3507.
81. Salibián A, Montalti D. 2009. Physiological and biochemical aspects of the avian uropygial gland. Braz J Biol 69:437-446.
82. Salvesen GS, Duckett CS. 2002. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410.
83. Schneider MR, Paus R. 2010. Sebocytes, multifaceted epithelial cells: lipid production and holocrine secretion. Int J Biochem Cell Biol 42:181-185.
84. Selleri S, Seltmann H, Gariboldi S, Shirai YF, Balsari A, Zouboulis CC, Rumio C. 2006. Doxorubicin-induced alopecia is associated with sebaceous gland degeneration. J Invest Dermatol 126:711-720.
85. Shawkey MD, Pillai SR, Hill GE. 2003. Chemical warfare? Effects of uropygial oil on feather-degrading bacteria. J Avian Biol 34:345-349.
86. Smith KR, Thiboutot DM. 2008. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J Lipid Res 49:271-281.
87. Song Y, Yaar M, Gilchrest BA. 1996. Evidence that Bax mediates keratinocyte differentiation and apoptosis. J Invest Dermatol 106:875.
88. Stauber RH, Mann W, Knauer SK. 2007. Nuclear and cytoplasmic survivin: molecular mechanism, prognostic, and therapeutic potential. Cancer Res 67:5999-6002.
89. Suzuki T. 1994. Ultrastructural studies on the uropygial glands of quails. Jpn Poult Sci 31:38-44.
90. Tamada Y, Takama H, Kitamura T, Yokochi K, Nitta Y, Ikeya T, Matsumoto Y. 1994. Identification of programmed cell death in normal human skin tissues by using specific labelling of fragmented DNA. Br J Dermatol 131:521-524.
91. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC. 1998. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58:5315-5320.
92. Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM. 2000. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 102:451-461.
93. Temme A, Rodriguez JA, Hendruschk S, Günes S, Weigle B, Schäkel K, Schmitz M, Bachmann M, Schackert G, Rieber EP. 2007. Nuclear localization of survivin renders HeLa tumor cells more sensitive to apoptosis by induction of p53 and Bax. Cancer Lett 250:177-193.
94. Thody AJ, Shuster S. 1989. Control and function of sebaceous glands. Physiol Rev 69:383-416.
95. Tomkova H, Fujimoto W, Arata, J. 1998. Expression of the bcl-2 homologue Bax in normal human skin, psoriasis vulgaris and non-melanoma skin cancers. Eur J Dermatol 8:256-260.
96. Wheatley SP, McNeish IA. 2005. Survivin: a protein with dual roles in mitosis and apoptosis. Int Rev Cytol 247:35-88.
97. Witko-Sarsat V, Mocek J, Bouayad D, Tamassia N, Ribeil J-A, Candalh C, Davezac N, Reuter N, Mouthon L, Hermine O, Pederzoli-Ribeil M, Cassatella MA. 2010. Proliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survival. J Exp Med 207:2631-2645.
98. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. 1997. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281-1292.
99. Wood RD, Shivji MKK. 1997. Which DNA polymerases are used for DNA-repair in eukaryotes? Carcinogenesis 18:605-610.
100. Wu Y-Y, Takata M, Rehman I, Rees JL. 2000. The temporal and spatial distribution of p21WAF expression in skin appendages. Br J Dermatol 142:694-701.
101. Wróbel A, Seltmann H, Fimmel S, Müller-Decker K, Tsukada M, Bogdanoff B, Mandt N, Blume-Peytavi U, Orfanos CE, Zouboulus CC. 2003. Differentiation and apoptosis in human immortalized sebocytes. J Invest Dermatol 120:175-181.
102. Yang YL, Li XM. 2000. The IAP family: endogenous caspase inhibitors with multiple biological activities. Cell Res 10:169-177.
103. Yang D, Welm A, Bishop JM. 2004. Cell division and cell survival in the absence of survivin. Proc Natl Acad Sci USA 101:15100-15105.
104. Zouboulis CC. 2000. Human skin: an independent peripheral endocrine organ. Hormone Res 54:230-242.
105. Zouboulis CC. 2003. Sebaceous gland in human skin-the fantastic future of a skin appendage. J Invest Dermatol 120:905-914.